rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert Glassman

Director

Company insider

Files Form 4 as: Director, Pharvaris.

Every Form 4 they filed

In numbers

Trades disclosed
26
Buys
0
Sells
4
Bought
$0
Sold
$3.0M
Companies
1
Companies where not an officer
1
First trade
15 May 2026
Last trade
17 Sep 2026
Last filed
21 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
PHVS PharvarisDirector · Biotechnology · last 17 Sep 20260 buys · 4 sells

Activity over time

1 May – 1 Oct
30May 26Jun 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$263K14,493 at $18.14filing
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$559K14,493 at $38.56filing
17 Sep 2026filed 21 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—14,493 at $0.00filing
17 Sep 2026filed 21 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—14,493 at $0.00filing
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$263K14,493 at $18.14filing
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$559K14,493 at $38.56filing
15 Sep 2026filed 17 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$193K8,667 at $22.31filing
15 Sep 2026filed 17 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$332K8,667 at $38.27filing
15 Sep 2026filed 17 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—8,667 at $0.00filing
15 Sep 2026filed 17 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—8,667 at $0.00filing
15 Sep 2026filed 17 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$193K8,667 at $22.31filing
15 Sep 2026filed 17 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$332K8,667 at $38.27filing
9 Sep 2026filed 11 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$160K8,000 at $20.00filing
9 Sep 2026filed 11 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$300K8,000 at $37.55filing
9 Sep 2026filed 11 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—8,000 at $0.00filing
9 Sep 2026filed 11 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—8,000 at $0.00filing
9 Sep 2026filed 11 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$160K8,000 at $20.00filing
9 Sep 2026filed 11 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$300K8,000 at $37.55filing
15 May 2026filed 19 May 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$119K5,333 at $22.31filing
15 May 2026filed 19 May 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$159K5,333 at $29.83filing

News

Pharvaris (NASDAQ:PHVS) Director Robert Glassman Sells 8,000 Sharestickerreport.com · 11 Sep 2026

1 headline in the last 90 days name Robert Glassman; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Peng LuPresident · President at Pharvaris, filing Form 4 there in the last year
Viviane MongesDirector · Director at Pharvaris, filing Form 4 there in the last year
Johannes Gerardus Christiaan Petrus SchikanDirector · Director at Pharvaris, filing Form 4 there in the last year
David W. NassifCFO / CLO · CFO / CLO at Pharvaris, filing Form 4 there in the last year
Elisabeth BjorkDirector · Director at Pharvaris, filing Form 4 there in the last year
Anne LesageChief Early Development · Also traded PHVS in the last 90 days
Stefan Andreas AbeleChief Technical Ops Officer · Also traded PHVS in the last 90 days
Wim SouverijnsChief Commercial Officer · Also traded PHVS in the last 90 days